» Articles » PMID: 22159077

Processing and Stability of Type IIc Sodium-dependent Phosphate Cotransporter Mutations in Patients with Hereditary Hypophosphatemic Rickets with Hypercalciuria

Overview
Specialties Cell Biology
Physiology
Date 2011 Dec 14
PMID 22159077
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the apically located Na(+)-dependent phosphate (NaPi) cotransporter, SLC34A3 (NaPi-IIc), are a cause of hereditary hypophosphatemic rickets with hypercalciuria (HHRH). We have characterized the impact of several HHRH mutations on the processing and stability of human NaPi-IIc. Mutations S138F, G196R, R468W, R564C, and c.228delC in human NaPi-IIc significantly decreased the levels of NaPi cotransport activities in Xenopus oocytes. In S138F and R564C mutant proteins, this reduction is a result of a decrease in the V(max) for P(i), but not the K(m). G196R, R468W, and c.228delC mutants were not localized to oocyte membranes. In opossum kidney (OK) cells, cell surface labeling, microscopic confocal imaging, and pulse-chase experiments showed that G196R and R468W mutations resulted in an absence of cell surface expression owing to endoplasmic reticulum (ER) retention. G196R and R468W mutants could be partially stabilized by low temperature. In blue native-polyacrylamide gel electrophoresis analysis, G196R and R468W mutants were either denatured or present in an aggregation complex. In contrast, S138F and R564C mutants were trafficked to the cell surface, but more rapidly degraded than WT protein. The c.228delC mutant did not affect endogenous NaPi uptake in OK cells. Thus, G196R and R468W mutations cause ER retention, while S138F and R564C mutations stimulate degradation of human NaPi-IIc in renal epithelial cells. Together, these data suggest that the NaPi-IIc mutants in HHRH show defective processing and stability.

Citing Articles

An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

Zhu Z, Bo-Ran Ho B, Chen A, Amrhein J, Apetrei A, Carpenter T Kidney Int. 2024; 105(5):1058-1076.

PMID: 38364990 PMC: 11106756. DOI: 10.1016/j.kint.2024.01.031.


Family analysis and literature study of hereditary hypophosphatemic rickets with hypercalciuria.

Wang L, Kulaixi G, Zaiyinati J, Aibai G, Du D, Guo Y BMC Pediatr. 2024; 24(1):121.

PMID: 38355430 PMC: 10865686. DOI: 10.1186/s12887-024-04589-2.


Skeletal and extraskeletal disorders of biomineralization.

Collins M, Marcucci G, Anders H, Beltrami G, Cauley J, Ebeling P Nat Rev Endocrinol. 2022; 18(8):473-489.

PMID: 35578027 DOI: 10.1038/s41574-022-00682-7.


Genomics Integration Into Nephrology Practice.

Pinto E Vairo F, Prochnow C, Kemppainen J, Lisi E, Steyermark J, Kruisselbrink T Kidney Med. 2021; 3(5):785-798.

PMID: 34746741 PMC: 8551494. DOI: 10.1016/j.xkme.2021.04.014.


Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.

Rush E, Johnson B, Aradhya S, Beltran D, Bristow S, Eisenbeis S J Bone Miner Res. 2021; 37(2):202-214.

PMID: 34633109 PMC: 9298723. DOI: 10.1002/jbmr.4454.